Please download the press release for further details.

We are pleased to announce that Biomonitor has acquired Neutekbio Ltd. on 27. November 2008. Neutekbio has a proprietary platform of products based on reporter gene technology and developed cell-based assays and kits called iLite™ , which complement Biomonitor’s offerings in assays for patient monitoring and biopharmaceutical drug development programs.

For further information please contact:
Arsalan Kharazmi, CEO, Biomonitor A/S.  E-mail: ak @ biomon.dk, Phone: +45 39179797
Søren Lemonius, Partner, Sunstone Capital A/S,  E-mail: Lemonius @ sunstonecapital.com, Phone: +45 40814889